miRNA-21 as a novel therapeutic target in lung cancer
Athina Markou, Martha Zavridou, Evi S LianidouAnalysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, GreeceAbstract: Lung cancer is a leading cause of cancer death, and late diagnosis is one of the most important reasons for th...
Guardado en:
Autores principales: | Markou A, Zavridou M, Lianidou ES |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f12b5a6c1d848f18754a272b4f21f47 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value
por: Garcia-Valdecasas Gayo Sonsoles, et al.
Publicado: (2020) -
miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
por: Li F, et al.
Publicado: (2018) -
Role of afatinib in the treatment of advanced lung squamous cell carcinoma
por: Vavalà T
Publicado: (2017) -
MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer
por: Hongli Pan, et al.
Publicado: (2021) -
Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients
por: Motamedi M, et al.
Publicado: (2019)